Survivin peptides as cancer vaccines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S093710, C424S277100, C435S372000, C514S019300, C514S021400, C514S021500, C514S021600, C530S326000, C530S327000, C530S328000

Reexamination Certificate

active

07943138

ABSTRACT:
Provided are compositions and methods for treating survivin expressing cancers. The compositions contain peptide survivin peptide mimics with improved MHC-I binding characteristics. The method involves administering a survivin peptide mimic with improved MHC-I binding characteristics to an individual to effect inhibition of the growth of survivin expressing cancer cells in the individual.

REFERENCES:
patent: 2004/0176573 (2004-09-01), Thor et al.
patent: 2006/0073159 (2006-04-01), Vonderheide et al.
patent: 2007/0083334 (2007-04-01), Mintz et al.
patent: 2007/0104689 (2007-05-01), Gillies et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Survivin peptides as cancer vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Survivin peptides as cancer vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Survivin peptides as cancer vaccines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2654547

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.